Company Filing History:
7 out of 8 
2 out of 5,313 
2 out of 2 
Years Active: 2015-2025
Title: Ruby Yanru Tsai: Innovator in Genetic Screening and Cell Therapy
Introduction
Ruby Yanru Tsai is a prominent inventor based in San Jose, California. She has made significant contributions to the fields of genetic screening and cell transplantation therapy. With a total of 11 patents to her name, her work has advanced the understanding and application of genetic technologies.
Latest Patents
Among her latest patents are innovative methods for screening variants of target genes. These methods provide a framework for identifying desired variants in a eukaryotic system. Additionally, she has developed compositions for screening these variants. Another notable patent involves HLA-F-modified cells and methods, which focus on cell transplantation therapy. This patent details the forced expression of an exogenous HLA-F protein in donor cells, enhancing their compatibility for transplantation.
Career Highlights
Ruby has worked with esteemed organizations such as Applied Stemcell, Inc. and Leland Stanford Junior University. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Alfonso Farruggio and Ling-Jie Kong. Their collaborative efforts have furthered the impact of her inventions and research.
Conclusion
Ruby Yanru Tsai's innovative work in genetic screening and cell therapy exemplifies her dedication to advancing medical science. Her patents reflect her commitment to improving healthcare through technology.